CN105527285B - One kind proves that adamantane and beta cyclodextrin assemble successful method - Google Patents

One kind proves that adamantane and beta cyclodextrin assemble successful method Download PDF

Info

Publication number
CN105527285B
CN105527285B CN201510967042.7A CN201510967042A CN105527285B CN 105527285 B CN105527285 B CN 105527285B CN 201510967042 A CN201510967042 A CN 201510967042A CN 105527285 B CN105527285 B CN 105527285B
Authority
CN
China
Prior art keywords
adamantane
beta
assemble
schardinger dextrin
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510967042.7A
Other languages
Chinese (zh)
Other versions
CN105527285A (en
Inventor
雷忠利
舒士倡
杨红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Normal University
Original Assignee
Shaanxi Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Normal University filed Critical Shaanxi Normal University
Priority to CN201510967042.7A priority Critical patent/CN105527285B/en
Publication of CN105527285A publication Critical patent/CN105527285A/en
Application granted granted Critical
Publication of CN105527285B publication Critical patent/CN105527285B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/82Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Prove that adamantane and beta cyclodextrin assemble successful method the invention discloses one kind,After this method is for proving that the adamantane of host molecule sulfydryl beta cyclodextrin and the modification of guest molecule pH sensitive polymers is reacted by host-guest chemistry,Whether adamantane and beta cyclodextrin assemble success,It utilizes the interaction between sulfydryl on gold and host molecule,Gold is set to be attached on host molecule,Then by adjusting pH value,It is in hydrophobic state to make the pH sensitive polymers in guest molecule,If adamantane and beta cyclodextrin assemble successfully,The host molecule of guest molecule and combination gold precipitates simultaneously,There is the generation of purple floccule and upper strata is colorless cleared solution,If adamantane and beta cyclodextrin are unassembled,Then only has guest molecule precipitation (White Flocculus),It is present in reference to the host molecule of gold in upper solution,I.e. upper strata is purple settled solution.The present invention does not need large-scale instrument detection, and cost is relatively low, and testing result accuracy is high.

Description

One kind proves that adamantane and beta-schardinger dextrin assemble successful method
Technical field
The invention belongs to be tested or analysis of material technical field by means of determining the chemically or physically property of material, it is related to One kind proves that adamantane and beta-schardinger dextrin assemble successful method.
Background technology
Inclusion compound is that a kind of space structure of molecule completely or partially wraps into another molecule and formed, and has clathration Outer layer molecule is referred to as host molecule, is referred to as guest molecule by the small-molecule substance included among host molecule, therefore inclusion compound is again Claim " molecular capsule ".In terms of medicament slow release, inclusion compound, can be with due to suitable particle diameter, excellent pharmaceutical carrier function As a kind of pharmaceutical carrier.Because the pH value of cancer cell tissue is lower than the pH value of human normal tissue, Medicated Permeation rate is poor, institute In design medicine carrier, pharmaceutical carrier is designed as into pH sensitive properties and there is stronger permeability, have broader Actual use value.
Beta-schardinger dextrin, can conduct because its structure has the particularity of " outer hydrophilic, interior hydrophobic " and nontoxic premium properties Host molecule and a variety of guest inclusions, such as adamantane.But when preparing inclusion compound material, whether Subjective and Objective, which assembles, is successfully A very crucial step, at present generally with the technology such as ultraviolet spectra, mass spectrum, transmission electron microscope, laser particle analyzer to beta-schardinger dextrin and its Inclusion compound is characterized.But these are all to go to detect by laboratory apparatus.Certainly, due to many laboratories because condition limits System, the material worked it out is not very pure, so by experimental method, and be very difficult to characterize.
The content of the invention
The technical problems to be solved by the invention be to provide it is a kind of it is simple to operate, do not need large-scale instrument detection to demonstrate,prove Bright adamantane and beta-schardinger dextrin assemble successful method.
Technical scheme is used by solving above-mentioned technical problem:By host molecule mercapto group-beta-cyclodextrin and guest molecule After the adamantane that pH sensitive polymers are modified is reacted by host-guest chemistry, products therefrom adds the N of gold chloride, N- dimethyl In amide solution, react 12~24 hours at normal temperatures, centrifuge, gained solid is dissolved completely in deionized water, use Acid or alkali adjust its pH value to pH sensitive polymers and are the pH value of hydrophobic state, if having, purple floccule generates and upper strata is nothing Color settled solution, it was demonstrated that adamantane and beta-schardinger dextrin assemble successfully, and White Flocculus generates and upper strata is that purple clarification is molten if having Liquid, illustrate that adamantane and beta-schardinger dextrin are unassembled.
The concentration of the N of above-mentioned gold chloride, N- DMF solution is preferably 5~15g/L, gold chloride and sulfydryl-β-ring The mol ratio of dextrin is 1:1~1.5.
Above-mentioned pH sensitive polymers are the polymerized monomer with amino and carboxyl, specific such as polymethylacrylic acid (its The pH value of hydrophobic state is less than 5.6), (its is hydrophobic for polyacrylamide for polyacrylic acid (pH value of its hydrophobic state is less than 5.4) The pH value of state is 10~13) etc..
Above-mentioned acid is boric acid, hydrochloric acid, nitric acid etc., and alkali is sodium hydroxide, potassium hydroxide etc..
The present invention makes gold be attached to main body using the interaction between sulfydryl on gold and host molecule mercapto group-beta-cyclodextrin On molecule, then by adjusting pH value, it is in hydrophobic state to make the pH sensitive polymers in guest molecule, if adamantane and β-ring Dextrin assembles successfully, and the host molecule of guest molecule and combination gold precipitates simultaneously, that is, has the generation of purple floccule and upper strata is nothing Color settled solution, if adamantane and beta-schardinger dextrin are unassembled, only guest molecule precipitates (White Flocculus), with reference to the master of gold Body molecule is present in upper solution, i.e., upper strata is purple settled solution.
The present invention is used for the Buddha's warrior attendant for proving that host molecule mercapto group-beta-cyclodextrin is modified with guest molecule pH sensitive polymers After alkane is reacted by host-guest chemistry, whether adamantane and beta-schardinger dextrin assemble success, and method is simple to operate, it is not necessary to large-scale instrument Device detects, and cost is relatively low, and testing result accuracy is high.
Brief description of the drawings
Fig. 1 is AD-PMAA (a), β-CD- (SH)7(b), AD-PMAA and β-CD- (SH)7Physical mixed (c), β-CD- (SH)7/ AD-PMAA (d) X-ray diffractogram.
Fig. 2 is AD-PMAA, β-CD- (SH)7、β-CD-(SH)7/ AD-PMAA Laser particle-size distribution figure.
Fig. 3 is β-CD- (SH) when pH is 5.67/ AD-PMAA transmission electron microscope picture.
Embodiment
The present invention is described in more detail with reference to the accompanying drawings and examples, but protection scope of the present invention is not limited only to These embodiments.
The preparation method for the adamantane that polymethylacrylic acid in example below is modified is:According to document (L.Yang, Y.Guo and Z.Lei,J.Mater.Chem.A,2015,DOI:10.1039/C5TA03937A) synthesis polymethylacrylic acid uncle The adamantane (being denoted as AD-PTBMA) that butyl ester is modified, AD-PTBMA is dissolved in dry dichloromethane, in a nitrogen atmosphere, The trifluoroacetic acid of 5 times of AD-PTBMA moles is added, solvent, residue is evaporated off after 36 hours, with Rotary Evaporators in normal-temperature reaction Matter is fitted into after being dissolved with tetrahydrofuran in the bag filter that molecular weight is 1000, and a water is changed in gap for 3 hours, dialyses 3 days, finally will Dialyzate is freeze-dried, and the adamantane for obtaining the modification of guest molecule polymethylacrylic acid (is denoted as AD-PMAA, it counts equal molecule Measure as 10000).
Embodiment 1
0.1g (0.1mmol) host molecule mercapto group-beta-cyclodextrin (is denoted as β-CD- (SH)7) and 1g (0.1mmol) object Molecule AD-PMAA is dissolved completely in 50mL deionized waters, stirring at normal temperature 24 hours, and freeze-drying, products therefrom is denoted as β-CD- (SH)7/AD-PMAA。
By products therefrom β-CD- (SH)7/ AD-PMAA adds the N of 34mL 10g/L gold chlorides, N- DMF solutions In, stirring at normal temperature 12 hours, centrifuge, gained solid is dissolved completely in 25mL deionized waters, with boron acid for adjusting pH value To less than 5.6, if having, purple floccule is generated and upper strata is colorless cleared solution, it was demonstrated that adamantane and beta-schardinger dextrin are assembled into Work(, if having, White Flocculus generates and upper strata is purple settled solution, illustrates that adamantane and beta-schardinger dextrin are unassembled.Inventor uses To 2.0, experimental result is shown boron acid for adjusting pH value, has the generation of purple floccule and upper strata is colorless cleared solution, it was demonstrated that Buddha's warrior attendant Alkane and beta-schardinger dextrin assemble successfully.
The above method can also be used for proving the adamantane (example that mercapto group-beta-cyclodextrin is modified with other pH sensitive polymers Such as modified adamantane of polyacrylic acid, polyacrylic acid, polyacrylamide) self assembly success or not, pH value need to only be adjusted to PH value when corresponding pH sensitive polymers are hydrophobic state, if having, purple floccule generates and upper strata is colorless cleared solution, Prove that adamantane and beta-schardinger dextrin assemble successfully, White Flocculus generates and upper strata is purple settled solution if having, and illustrates Buddha's warrior attendant Alkane and beta-schardinger dextrin are unassembled.
In order to prove the accuracy of the inventive method, inventor is using X-ray diffractometer, laser particle analyzer, transmitted electron Microscope is respectively to the products therefrom β-CD- (SH) of embodiment 17/ AD-PMAA is characterized, and as a result sees Fig. 1~3.
In Fig. 1, can clearly judge it is AD-PMAA and β-CD- (SH) from curve c7The simple superposition of spectrogram, and In curve d, AD-PMAA and β-CD- (SH)7Crystal characteristic peak disappear, there is new crystal diffraction characteristic peak, illustrate formation New solid phase, i.e. AD-PMAA and β-CD- (SH)7Interact to form inclusion compound by weak chemical bond, it is possible to determine that β- CD-(SH)7There is adamantane and the host -guest inclusion complex of beta-schardinger dextrin in/AD-PMAA.
From Figure 2 it can be seen that β-CD- (SH)7/ AD-PMAA particle diameter is more bigger than guest molecule AD-PMAA particle diameter, explanation Subjective and Objective successfully assembles.As seen from Figure 3, when pH is 5.6, β-CD- (SH)7/ AD-PMAA forms globular micelle, because For when 5.6, PMAA is hydrophobic, and β-CD- (SH)7It is hydrophily, can shape so only having them successfully to assemble Into micella.And as seen from Figure 3, between 100~200nm, the testing result with laser particle analyzer is the particle diameter of micella Consistent, further illustrate AD-PMAA and β-CD- (SH)7Successfully assemble.
From the above experiments, it was found that present invention demonstrates that method shows with X-ray diffractometer, laser particle analyzer, transmitted electron Micro mirror testing result is consistent, and it is to prepare reliably to illustrate the inventive method.

Claims (6)

1. one kind proves that adamantane and beta-schardinger dextrin assemble successful method, it is characterised in that:By host molecule sulfydryl-β-ring paste After the adamantane that essence is modified with guest molecule pH sensitive polymers is reacted by host-guest chemistry, products therefrom adds gold chloride N, in N- DMF solutions, react 12~24 hours at normal temperatures, centrifuge, gained solid is dissolved completely in In ionized water, adjusted its pH value to pH sensitive polymers with acid or alkali and be the pH value of hydrophobic state, if there is the life of purple floccule Into and upper strata be colorless cleared solution, it was demonstrated that adamantane and beta-schardinger dextrin assemble successfully, if having White Flocculus generate and upper strata For purple settled solution, illustrate that adamantane and beta-schardinger dextrin are unassembled.
2. proof adamantane according to claim 1 and beta-schardinger dextrin assemble successful method, it is characterised in that:The chlorine The concentration of the N of auric acid, N- DMF solution is 5~15g/L.
3. proof adamantane according to claim 1 or 2 and beta-schardinger dextrin assemble successful method, it is characterised in that:Institute The mol ratio for stating gold chloride and mercapto group-beta-cyclodextrin is 1:1~1.5.
4. proof adamantane according to claim 1 and beta-schardinger dextrin assemble successful method, it is characterised in that:Described PH sensitive polymers are any one in polymethylacrylic acid, polyacrylic acid, polyacrylamide.
5. proof adamantane according to claim 1 and beta-schardinger dextrin assemble successful method, it is characterised in that:Described Acid is any one in boric acid, hydrochloric acid, nitric acid.
6. proof adamantane according to claim 1 and beta-schardinger dextrin assemble successful method, it is characterised in that:Described Alkali is sodium hydroxide or potassium hydroxide.
CN201510967042.7A 2015-12-21 2015-12-21 One kind proves that adamantane and beta cyclodextrin assemble successful method Expired - Fee Related CN105527285B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510967042.7A CN105527285B (en) 2015-12-21 2015-12-21 One kind proves that adamantane and beta cyclodextrin assemble successful method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510967042.7A CN105527285B (en) 2015-12-21 2015-12-21 One kind proves that adamantane and beta cyclodextrin assemble successful method

Publications (2)

Publication Number Publication Date
CN105527285A CN105527285A (en) 2016-04-27
CN105527285B true CN105527285B (en) 2018-03-06

Family

ID=55769642

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510967042.7A Expired - Fee Related CN105527285B (en) 2015-12-21 2015-12-21 One kind proves that adamantane and beta cyclodextrin assemble successful method

Country Status (1)

Country Link
CN (1) CN105527285B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106634586B (en) * 2016-12-15 2020-02-18 东南大学 Preparation method of self-repairing transparent film of host and guest
CN112111260B (en) * 2020-10-09 2022-06-24 西南石油大学 Displacement leading edge outburst locking agent system and preparation method thereof
CN114291909B (en) * 2021-12-21 2023-09-08 宁夏理工学院 Scale inhibition dispersing agent

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1278061A1 (en) * 2001-07-19 2003-01-22 Sony International (Europe) GmbH Chemical sensors from nanoparticle/dendrimer composite materials
CN101721711A (en) * 2009-08-07 2010-06-09 南开大学 Method for preparing phenanthroline ruthenium cyclodextrin-adamantane pyrene-single wall carbon nanometer pipe ternary ultramolecular system and application thereof
CN102580113A (en) * 2012-03-02 2012-07-18 华东师范大学 Method for producing cis-platinum supermolecule micelle prodrug
CN102698286A (en) * 2012-07-02 2012-10-03 南开大学 Supramolecule assembly of targeting-delivery anticancer adamplatin and preparation of supramolecule assembly
CN103524751A (en) * 2013-09-11 2014-01-22 江南大学 Preparation method of double-sensitivity cyclodextrin supermolecule aggregate
CN103992483A (en) * 2014-05-13 2014-08-20 同济大学 A drug delivery material with sugar, temperature and pH triple sensitivities and a preparing method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1278061A1 (en) * 2001-07-19 2003-01-22 Sony International (Europe) GmbH Chemical sensors from nanoparticle/dendrimer composite materials
CN101721711A (en) * 2009-08-07 2010-06-09 南开大学 Method for preparing phenanthroline ruthenium cyclodextrin-adamantane pyrene-single wall carbon nanometer pipe ternary ultramolecular system and application thereof
CN102580113A (en) * 2012-03-02 2012-07-18 华东师范大学 Method for producing cis-platinum supermolecule micelle prodrug
CN102698286A (en) * 2012-07-02 2012-10-03 南开大学 Supramolecule assembly of targeting-delivery anticancer adamplatin and preparation of supramolecule assembly
CN103524751A (en) * 2013-09-11 2014-01-22 江南大学 Preparation method of double-sensitivity cyclodextrin supermolecule aggregate
CN103992483A (en) * 2014-05-13 2014-08-20 同济大学 A drug delivery material with sugar, temperature and pH triple sensitivities and a preparing method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Synthesis of a smart Janus-like supramolecular polymer based on the host–guest chemistry and its self-assembly";Long Yang 等;《Journal of Materials Chemistry A》;20150708;第3卷;第17098-17105页 *
"基于环糊精包结络合作用的大分子自组装";郭明雨 等;《化学进展》;20070430;第19卷(第4期);第557-566页 *
"智能聚合物包覆的金纳米粒子";罗春华 等;《化学进展》;20091231;第21卷(第12期);第2674-2681页 *
"环糊精超分子组装体与核酸的相互作用";陈湧 等;《有机化学》;20121231;第32卷;第805-814页 *

Also Published As

Publication number Publication date
CN105527285A (en) 2016-04-27

Similar Documents

Publication Publication Date Title
CN105527285B (en) One kind proves that adamantane and beta cyclodextrin assemble successful method
Filippousi et al. Modified chitosan coated mesoporous strontium hydroxyapatite nanorods as drug carriers
Basuki et al. Magnetic nanoparticles with diblock glycopolymer shells give lectin concentration-dependent MRI signals and selective cell uptake
Pati et al. Development of chitosan–tripolyphosphate fibers through pH dependent ionotropic gelation
Yeroslavsky et al. Sonochemically produced polydopamine nanocapsules with selective antimicrobial activity
Ali et al. A new study of iodine complexes of oxidized gum arabic: an interaction between iodine monochloride and aldehyde groups
KR20160127827A (en) Self-assembling peptide compositions
Cho et al. Removal of methyl violet dye by adsorption onto N-benzyltriazole derivatized dextran
Vishnevetskii et al. l-Cysteine as a reducing/capping/gel-forming agent for the preparation of silver nanoparticle composites with anticancer properties
Zeynep et al. Double hydrophilic polyphosphoester containing copolymers as efficient templating agents for calcium carbonate microparticles
Wu et al. Self-assembly of sodium glycyrrhetinate into a hydrogel: characterisation and properties
da Luz et al. Nanosilica-chitosan hybrid materials: preparation, characterization and application in aqueous drilling fluids
Wang et al. Smart flocculant with temperature and pH response derived from starch
Mihai et al. Autotemplate microcapsules of CaCO3/pectin and nonstoichiometric complexes as sustained tetracycline hydrochloride delivery carriers
CN104016348A (en) Application of diethylenetriamine propyl trimethoxy silane in preparing water-soluble silicon quantum dot
CN107001049B (en) The separation method of detonation Nano diamond
Li et al. Illustration and application of enhancing effect of arginine on interactions between nano-clays: Self-healing hydrogels
Wang et al. Atom-economical in situ synthesis of BaSO 4 as imaging contrast agents within poly (N-isopropylacrylamide) microgels using one-step droplet microfluidics
CN102690521A (en) Nano-magnetic silicon rubber as well as preparation method and application thereof
Ledin et al. Branched polyhedral oligomeric silsesquioxane nanoparticles prepared via strain-promoted 1, 3-dipolar cycloadditions
Mihai et al. Calcium carbonate microparticles growth templated by an oxadiazole-functionalized maleic anhydride-co-N-vinyl-pyrrolidone copolymer, with enhanced pH stability and variable loading capabilities
Zhao et al. Synthesis and characterization of arginine-modified and europium-doped hydroxyapatite nanoparticle and its cell viability
CN110028054B (en) Water-soluble fullerene derivative with determined structure and preparation method and application thereof
KR102142386B1 (en) Surface-treated sol-gel silica and its manufacturing method
JP5486750B2 (en) Gold fine particle coating, method for producing the same, and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180306

Termination date: 20201221